News & Updates

Urinary incontinence linked to functional, social limitations

23 Jan 2024

Urinary incontinence (UI) in women appears to be strongly associated with future disability, especially in the domains of mobility and social interaction, according to a study.

Urinary incontinence linked to functional, social limitations

23 Jan 2024

First local study an eye opener on the impact of ED on spouse

22 Jan 2024 by

Erectile dysfunction (ED) not only affects patients but also their spouse, as shown in the first such local study. [Malays Fam Physician 2023;18:44]*

First local study an eye opener on the impact of ED on spouse

22 Jan 2024

Survivors cope with life after testicular cancer

13 Jan 2024

Testicular cancer survivors (TCSs) demonstrate similar health-related quality of life (HRQoL) to that of the general population at a median of 28 years since treatment initiation, reports a study.

Survivors cope with life after testicular cancer

13 Jan 2024

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

21 Dec 2023 by

The combination of abiraterone plus prednisolone appears to have similar efficacy and safety as enzalutamide in the treatment of patients with nonmetastatic castration-resistant prostate cancer, according to a study.

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

21 Dec 2023

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

13 Dec 2023 by

In the second interim analysis of the Asian cohort from the phase III MAGNITUDE study, a combination regimen comprising niraparib and abiraterone acetate plus prednisone (NIRA-AAP) improved clinical outcomes in patients with BRCA+ metastatic castration-resistant prostate cancer (mCRPC).

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

13 Dec 2023

Conservative intervention reduces LUTS in men

04 Dec 2023 by

Use of a standardized and manualized intervention in a primary care setting results in a sustained decrease in lower urinary tract symptoms (LUTS) in men compared with usual care, results of the TRIUMPH study have shown.

Conservative intervention reduces LUTS in men

04 Dec 2023

Flexible ureteroscopy slightly better than shock wave lithotripsy for paediatric renal stones

30 Nov 2023

Treatment with flexible ureteroscopy (FE) results in a significantly higher stone-free rate than shock wave lithotripsy (SWL) in children with renal stones, reports a study. No difference is seen in complication rate or fluoroscopy exposure time between groups, but operative times and hospital stay are longer with FU.

Flexible ureteroscopy slightly better than shock wave lithotripsy for paediatric renal stones

30 Nov 2023

Same-day discharge more preferable than inpatient RARP

30 Nov 2023 by

Most patients prefer same-day discharge (SDD) over inpatient robotic-assisted radical prostatectomy (RARP) because of its cost-effectiveness, reports a study. The SDD approach maintains similar satisfaction levels and has comparable rates of complications across institutions and differing surgeon experience.

Same-day discharge more preferable than inpatient RARP

30 Nov 2023

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

27 Nov 2023 by

A systematic review and meta-analysis by researchers from the University of Hong Kong has shown that the use of peripherally inserted central catheters (PICCs) is associated with a higher rate of complications than central lines in terminally ill cancer patients with central venous access devices (CVADs) for palliative care. No conclusions were reached regarding the use of totally implanted ports (PORTs), as no studies on PORTs were eligible for analysis.

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

27 Nov 2023

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

27 Nov 2023

In the treatment of older patients with metastatic castration-resistant prostate cancer (mCRPC) who are considered unsuitable candidates for standard cabazitaxel (CBZ) regimens, treatment with CBZ at 16 mg/m2 (biweekly CBZ16) plus prophylactic granulocyte colony–stimulating factor (G-CSF) at each cycle helps reduce the risk of higher grade neutropenia and/or neutropenic complications while yielding similar clinical outcomes, according to the results of the phase III CABASTY trial.

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

27 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Urinary incontinence linked to functional, social limitations

Urinary incontinence linked to functional, social limitations

First local study an eye opener on the impact of ED on spouse

First local study an eye opener on the impact of ED on spouse

Survivors cope with life after testicular cancer

Survivors cope with life after testicular cancer

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

Conservative intervention reduces LUTS in men

Conservative intervention reduces LUTS in men

Flexible ureteroscopy slightly better than shock wave lithotripsy for paediatric renal stones

Flexible ureteroscopy slightly better than shock wave lithotripsy for paediatric renal stones

Same-day discharge more preferable than inpatient RARP

Same-day discharge more preferable than inpatient RARP

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients

Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients